Heart-Healthy Dietary Patterns
Definition
Heart-healthy dietary patterns are overall patterns of food and beverage intake associated with reduced cardiovascular disease morbidity and mortality. Evidence derives from dietary patterns rather than single foods or nutrients, reflecting the reality that foods interact in the full dietary context. The 2026 AHA Scientific Statement defines a heart-healthy dietary pattern by 9 features applicable across the life course regardless of where food is procured. Named patterns that meet these criteria when implemented as intended include DASH, Mediterranean-style, pescatarian, and ovo/lacto vegetarian diets — all considered equivalent by the AHA.
Key Concepts
AHA Heart-Healthy Dietary Framework
Core Principle
- Dietary patterns, not single nutrients or foods, drive CV outcomes; heart-healthy patterns share a common architecture regardless of named pattern sources/diet-aha-2026 (very high)
- Should be established from age 1 and maintained lifelong; household food environments are transmitted across generations; key inflection points include adolescence and young adulthood sources/diet-aha-2026 (very high)
- Applies regardless of food source — home cooking, restaurants, schools, workplaces, or recreational venues sources/diet-aha-2026 (very high)
The 9 Features
- Energy balance: adjust intake to achieve healthy body weight; obesity affects 40% of US adults and contributes to T2DM, hypertension, and cardiovascular-kidney-metabolic syndrome; ≥150 min/week moderate-to-vigorous physical activity sources/diet-aha-2026 (very high)
- Vegetables and fruits: core of all heart-healthy patterns; all forms acceptable (fresh, frozen, canned without added sugar or sodium); whole fruit preferred over juice sources/diet-aha-2026 (very high)
- Whole grains: whole wheat, oats, brown rice, quinoa, barley, rye; associated with lower CVD, CHD, stroke, T2DM, and MetS risk; favorably modulate gut microbiota and reduce inflammatory cytokines sources/diet-aha-2026 (very high)
- Healthy protein sources: plant proteins first (legumes, nuts → lower CVD/CHD risk); non-fried fish (lower MI risk); low-fat dairy preferred; red and processed meat replaced with plant sources; fish oil supplements NOT recommended for primary prevention and may increase AF risk sources/diet-aha-2026 (very high)
- Fat quality over quantity: replace saturated fat (butter, lard, tropical oils) with polyunsaturated and monounsaturated fats (soybean, canola, olive oils) → reduced LDL-C; no upper limit on total fat from healthy unsaturated sources; SFA should remain <10% of energy sources/diet-aha-2026 (very high)
- Minimise ultraprocessed foods: Nova classification; high intake → overweight, CVD, T2DM, all-cause mortality; mechanistic basis incompletely characterised due to category heterogeneity sources/diet-aha-2026 (very high)
- Minimise added sugars: adults consuming ≥25% energy from added sugars have ~3× CVD mortality vs. <10%; sugar-sweetened beverages linked to obesity, T2DM, CHD, and CV mortality sources/diet-aha-2026 (very high)
- Reduce sodium, increase potassium: sodium raises BP, potassium lowers BP; sodium reduction effective in hypertensive and normotensive individuals (greatest in Black patients, older adults, diabetics); potassium-enriched salt substitutes reduce BP and CVD events sources/diet-aha-2026 (very high)
- Alcohol: no CV protection confirmed by Mendelian randomisation; linear dose-dependent relationship with BP from lowest intake; do not initiate; if consumed, limit; avoid for hypertension prevention/treatment (2025 AHA/ACC HT guideline) sources/diet-aha-2026 (very high)
Collateral Benefits
- One dietary pattern serves multiple disease prevention goals: T2DM, certain cancers, kidney disease, and cognitive health sources/diet-aha-2026 (very high)
- Dietary cholesterol no longer a primary CVD target; moderate egg consumption acceptable sources/diet-aha-2026 (very high)
- Supplements not needed for most individuals who follow this pattern; exceptions: pregnant women, some older adults, restricted diets sources/diet-aha-2026 (very high)
DASH Diet
Definition and Nutritional Profile
- Dietary Approaches to Stop Hypertension: low total fat (27% kcal), low SFA (6%), low dietary cholesterol (~150 mg/d), reduced sodium (1500–2300 mg/d); high fiber (>30 g/d), potassium (~4700 mg/d), magnesium, and calcium (~1250 mg/d for 2100 kcal level); promotes vegetables, fruits, whole grains, low-fat dairy, legumes, nuts; restricts red/processed meat and SSBs sources/diet-mets-nutrients-2020 (high), sources/dash-meddiet-cn-2023 (high)
Blood Pressure Evidence
- Meta-analysis (30 RCTs, n=5,545): DASH + lifestyle intervention → SBP −3.2 mmHg (95% CI −4.2 to −2.3), DBP −2.5 mmHg (95% CI −3.5 to −1.5) vs control diet; effect amplified with sodium <2400 mg/d, age <50, and in hypertensive patients not on medication sources/diet-mets-nutrients-2020 (high)
- Network meta-analysis vs 13 dietary patterns: ranked most effective for BP reduction — this is an indirect comparison only (see Contradictions) sources/diet-mets-nutrients-2020 (high)
- Head-to-head vs MedDiet (Filippou 2023, n=240, 3-month RCT, salt restriction background): DASH −11.9 mmHg office SBP vs control; DASH = MedDiet on 24h ambulatory SBP and DBP (gold standard: −1.9 mmHg between groups, P=0.64); DASH did NOT outperform salt restriction alone for 24h ambulatory DBP sources/dash-meddiet-cn-2023 (high)
- Meta-analysis (17,230 participants): MedDiet and DASH both more effective than low-fat diets for long-term BP management sources/diet-mets-nutrients-2020 (high)
Metabolic Syndrome Evidence
- Cross-sectional study (n=1,493 adults): high DASH adherence → 48% less MetS risk; lower BMI, waist circumference, and pro-inflammatory markers sources/diet-mets-nutrients-2020 (high)
- Paediatric cohort (n=425, age 6–18): 64% lower MetS risk with high DASH adherence; inverse associations with BP, fasting glucose, and abdominal obesity sources/diet-mets-nutrients-2020 (high)
- Meta-analysis (multiple cohorts): higher DASH adherence → RR 0.78 all-cause mortality, RR 0.78 CVD mortality, RR 0.84 cancer mortality, RR 0.82 T2DM incidence sources/diet-mets-nutrients-2020 (high)
- Middle-term interventions: BMI WMD −0.42 kg/m², waist circumference −1.05 cm sources/diet-mets-nutrients-2020 (high)
Heart Failure Evidence
- DASH + sodium restriction (1500 mg/d): decreases hs-cTnI −20% and NT-proBNP −23% vs control diet + high sodium — DASH reduces cardiac injury, sodium restriction reduces cardiac strain; derived from hypertensive non-HF populations, not confirmed in HF sources/dash-nutrients-2021 (medium)
- 3-week controlled DASH in HFpEF (n=14): reduced BP and arterial stiffness, improved ventricular diastolic function, reduced oxidative stress sources/dash-nutrients-2021 (medium)
- 6-month RCT in symptomatic chronic HF: DASH improved exercise capacity and quality of life vs usual care sources/dash-nutrients-2021 (medium)
- GOURMET-HF: home-delivered DASH post-HF hospitalisation reduced symptoms, physical limitations, and hospitalisations sources/dash-nutrients-2021 (medium)
- DASH adherence inversely associated with HF incidence across MESA and REGARDS cohorts; benefit consistent across HFrEF and HFpEF sources/dash-nutrients-2021 (medium)
- No large pragmatic RCT of DASH diet in diagnosed HF patients; not standard of care; ESC HF guidelines recommend only avoiding >5 g salt/day without specifying a comprehensive dietary plan sources/dash-nutrients-2021 (medium)
Mediterranean Diet
Definition and Nutritional Profile
- Plant-based pattern from Mediterranean basin countries: high intake of vegetables, fruits, whole grains, pulses, legumes, nuts, and EVOO as the primary fat source; moderate fermented alcohol (wine with meals); low-to-moderate fish/poultry; low red meat, butter, sweets, and SSBs sources/diet-mets-nutrients-2020 (high)
- Macronutrient profile: 35–45% kcal from fat (primarily MUFA/PUFA from EVOO and nuts), 15% protein, 40–45% CH — a high-fat, moderate-CH pattern contrasting with DASH (low-fat, high-CH) sources/diet-mets-nutrients-2020 (high), sources/dash-meddiet-cn-2023 (high)
- EVOO: primary MUFA source (oleic acid); rich in polyphenols with anti-inflammatory and antioxidant properties; improves insulin resistance, lipid profile, and endothelial function
- Recognised by UNESCO as an Intangible Cultural Heritage; endorsed by the 2015–2020 US Dietary Guidelines as an example of a healthy pattern sources/diet-mets-nutrients-2020 (high)
Blood Pressure Evidence
- Head-to-head vs DASH (Filippou 2023 RCT, n=240, 3 months, high-normal BP/grade 1 HT, Greek adults, never drug-treated):
- Office SBP: MedDiet −15.1 mmHg vs control; MedDiet superior to DASH (MDG vs DDG: −3.2 mmHg, 95% CI −5.4 to −1.0, P<0.001)
- 24h ambulatory SBP/DBP (gold standard): MedDiet = DASH (−1.9 mmHg SBP P=0.64; −2.1 mmHg DBP P=0.09)
- Night-time DBP: MedDiet marginally superior (−3.1 mmHg, P=0.02)
- Hypertension odds vs control: OR 0.02 (MedDiet) vs 0.03 (DASH); not significantly different sources/dash-meddiet-cn-2023 (high)
- Both MedDiet and DASH significantly outperform salt restriction alone for office and 24h ambulatory SBP sources/dash-meddiet-cn-2023 (high)
- The office SBP advantage of MedDiet may partly reflect greater white-coat effect attenuation and slightly greater urinary sodium reduction achieved in the MedDiet group sources/dash-meddiet-cn-2023 (high)
Metabolic Syndrome Evidence
- Meta-analysis (12 cross-sectional/prospective cohorts): higher MedDiet adherence → 19% lower MetS risk (RR 0.81; 95% CI 0.71–0.92); waist circumference RR 0.82; BP RR 0.87 sources/diet-mets-nutrients-2020 (high)
- CARDIA study (n=4,713, US): HR 0.67 (95% CI 0.49–0.90) for MetS development with high MedDiet adherence sources/diet-mets-nutrients-2020 (high)
- SU.VI.MAX (n=3,232, France, 6-year prospective): 53% lower MetS risk in highest MedDiet adherence tertile (OR 0.47–0.50) sources/diet-mets-nutrients-2020 (high)
- Korean adults: medium-to-high MedDiet adherence OR 0.64–0.73 for MetS sources/diet-mets-nutrients-2020 (high)
Cardiovascular Outcomes
- US Women's Health Study (n=25,994): highest MedDiet adherence score → CVD HR 0.72 (95% CI 0.61–0.86) sources/diet-mets-nutrients-2020 (high)
- Systematic review: MedDiet adherence → 38% lower CVD risk; reduces CHD, stroke, T2DM incidence and severity; associated with decreased all-cause and cancer mortality sources/diet-mets-nutrients-2020 (high)
- MedDiet reduces T2DM risk and body composition (total and segmental fat reduction) sources/diet-mets-nutrients-2020 (high)
Other Dietary Patterns (Summary)
Plant-Based Diets
- Broad category: vegan, lacto-ovo-vegetarian, pescatarian; MedDiet also qualifies as plant-predominant
- Meta-analysis (7 RCTs): vegetarian diet → SBP −4.8 mmHg, DBP −2.2 mmHg vs omnivorous; weight loss −2.88 kg (11 RCTs) sources/diet-mets-nutrients-2020 (high)
- 28% reduction in coronary heart disease risk (vegetarian diet); 38% lower CVD (MedDiet), 20% lower CVD (DASH) in systematic reviews sources/diet-mets-nutrients-2020 (high)
- "Plant-based" does not equal "healthy" — refined grains, pastries, and SSBs are plant-derived but harmful sources/diet-mets-nutrients-2020 (high)
Low-Carbohydrate and Ketogenic Diets
- Low-CH: <50% kcal from CH; ketogenic: <10% CH (~30–50 g/d) with high fat (30–70% kcal)
- Meta-analysis (18 studies, n=69,554): 2.5% increase in MetS risk per 5% energy from CH sources/diet-mets-nutrients-2020 (high)
- Ketogenic vs low-fat (Bueno meta-analysis): greater weight loss −0.91 kg, TG −0.18 mmol/L, DBP −1.43 mmHg, HDL-c +0.09 mmol/L; benefits likely driven by energy restriction rather than macronutrient distribution sources/diet-mets-nutrients-2020 (high)
- PURE cohort (n=135,335) and Seidelmann et al.: U-shaped CH-mortality relationship — optimal 50–55% kcal from CH; both high (>70%) and low (<40%) CH associated with increased total mortality sources/diet-mets-nutrients-2020 (high)
- AHA 2026: ketogenic diets may cause dramatic LDL-C elevation (case series); long-term CV impact uncertain sources/diet-aha-2026 (very high)
- Eliminates vegetables, fruits, and whole grains — foods independently associated with lower chronic disease risk sources/diet-mets-nutrients-2020 (high)
Low-Fat Diet
- <30% kcal from total fat, <10% SFA; higher CH (50–60% kcal)
- 18% lower all-cause mortality in obese adults with weight-loss interventions (34 RCTs) sources/diet-mets-nutrients-2020 (high)
- Conflicting results for MetS specifically; DIETFITS trial: equal weight loss with low-fat and low-CH — no difference between groups sources/diet-mets-nutrients-2020 (high)
- Short-term BP and lipid benefits inferior to MedDiet and DASH in long-term comparisons sources/diet-mets-nutrients-2020 (high)
Contradictions / Open Questions
- DASH vs. MedDiet for BP — network meta-analysis vs. direct RCT: Prior network meta-analyses (Schwingshackl et al.) ranked DASH as most effective for BP among 13 dietary patterns, including superiority over MedDiet by −3.31 mmHg SBP — but network arms were unequal, compromising randomisation. The first head-to-head RCT (Filippou 2023, n=240) shows MedDiet = DASH on 24h ambulatory BP (gold standard). Direct RCT evidence should take precedence for head-to-head clinical conclusions. sources/dash-meddiet-cn-2023 (high), sources/diet-mets-nutrients-2020 (high)
- MedDiet vs. AHA-equivalent patterns for MetS: Castro-Barquero 2020 designates MedDiet as the "new paradigm" for MetS treatment; AHA 2026 rates MedDiet, DASH, pescatarian, and vegetarian as equivalent without hierarchy. These reflect different evidence framings (MetS endpoints vs. broad CV outcomes), not irreconcilable data. sources/diet-mets-nutrients-2020 (high), sources/diet-aha-2026 (very high), sources/dash-meddiet-cn-2023 (high)
- Ketogenic diet: short-term MetS benefit vs. long-term CV safety: Bueno meta-analysis documents short-term metabolic improvements; AHA 2026 flags dramatic LDL-C elevation in case series and uncertain long-term CV impact; both sources agree energy restriction is likely the active mechanism. sources/diet-mets-nutrients-2020 (high), sources/diet-aha-2026 (very high)
- U-shaped CH-mortality curve vs. short-term low-CH MetS benefits: PURE/Seidelmann show optimal mortality at 50–55% CH; low-CH diets improve short-term MetS components but may increase long-term mortality especially when animal fat/protein replaces CH. Long-term mortality implications unresolved. sources/diet-mets-nutrients-2020 (high)
- DASH in HF — promise vs. evidence gap: Consistent observational associations with lower HF incidence and promising pilot data (hs-cTnI −20%, NT-proBNP −23%; HFpEF diastolic function improvement) but mechanistic data come from non-HF hypertensive populations. No large pragmatic RCT in diagnosed HF; not guideline-level recommendation. sources/dash-nutrients-2021 (medium)
- Fish oil supplement vs. dietary fish discordance: Non-fried dietary fish reduces CVD risk; fish oil supplementation does not reduce CVD risk in healthy adults and may increase AF risk. Disease-specific exception: omega-3 PUFA supplementation carries Class 2b, LOE B-R recommendation in NYHA II–IV HF (AHA 2023 CAM-in-HF). Both documents agree ≥4 g/day increases AF risk. sources/alt-medicine-hf-aha-2023 (very high), sources/diet-aha-2026 (very high)
- Dairy fat controversy: Low-fat dairy associated with lower CVD risk in some systematic reviews but not in studies examining dairy fat specifically as a saturated fat source. Current guidance conservatively recommends low-fat/nonfat dairy pending clearer evidence. sources/diet-aha-2026 (very high)
- Ultraprocessed food mechanisms: Consistent epidemiological association with CVD/T2DM/mortality; mechanistic basis poorly characterised due to Nova category heterogeneity. Causality vs. confounding and the specific harmful components (sodium, sugar, additives, lack of fibre) remain open. sources/diet-aha-2026 (very high)
- Alcohol — Mendelian randomisation vs. observational discordance: Prior J-shaped or U-shaped protective association in observational studies not confirmed by Mendelian randomisation; discrepancy likely reflects residual confounding. Current guidance: no initiation. sources/diet-aha-2026 (very high)
Connections
- Related to concepts/Metabolic-Syndrome — comparative dietary pattern evidence for MetS prevention and treatment
- Related to concepts/Hypertension-HMOD — sodium, potassium, DASH and MedDiet BP evidence; first-line non-pharmacological management
- Related to concepts/Blood-Pressure-Target-T2DM — dietary BP management in T2DM; DASH and MedDiet as adjunctive strategies
- Related to concepts/Dyslipidemia-Management — fat quality and LDL-C reduction; plant protein substitution for red meat
- Related to concepts/ASCVD-Risk-Assessment — dietary patterns as primary prevention modifiers
- Related to entities/Heart-Failure — DASH in HFpEF; sodium management; omega-3 adjunct therapy
- Related to entities/Atrial-Fibrillation — alcohol dose-dependent AF risk; fish oil supplement → increased AF risk
- Related to entities/Hypertension — sodium, potassium, and alcohol guidance; DASH and MedDiet first-line non-pharmacological treatment